FDA Finds Liver Risk In Generic Graves' Treatment
The U.S. Food and Drug Administration issued a warning Wednesday cautioning health care professionals that use of generic anti-thyroid drug propylthiouracil to treat hyperthyroidism and Graves' disease has been linked to...To view the full article, register now.
Already a subscriber? Click here to view full article